Medifast Launches Trilivy Metabolic Health System
BALTIMORE, July 17, 2026 Medifast, Inc. has announced the launch of Trilivy™, a comprehensive science-backed metabolic health system that...
metabolic health
Advertisement
Neurocrine’s CRENESSITY Delivers Two-Year Cardiometabolic Benefits in Adult CAH
SAN DIEGO, June 15, 2026 Neurocrine Biosciences has unveiled new two-year data from its Phase 3 CAHtalyst® Adult study,...
Caliway Presents CBL-514 Data Showing Reduced Weight Regain with GLP-1 Therapies
June 10, 2026 – Taipei, Taiwan Caliway Biopharmaceuticals announced new preclinical data demonstrating the potential of its proprietary fat-reduction...
Boehringer’s Survodutide Delivers Major Metabolic Benefits
INGELHEIM, Germany – June 7, 2026 Boehringer Ingelheim has reported positive Phase III results for its investigational glucagon/GLP-1 dual...
Antag Therapeutics Reports Positive Phase 1 Results for AT7687 in Obesity
COPENHAGEN, Denmark, June 7, 2026 Antag Therapeutics presented positive Phase 1 clinical results and new preclinical findings for AT7687,...
Advertisements
Zealand Pharma Reports Positive Phase 2 Petrelintide Data in Obesity
COPENHAGEN, Denmark, June 5, 2026 Zealand Pharma announced new results from its Phase 2 ZUPREME-1 clinical trial evaluating petrelintide,...
Zealand Pharma Highlights Positive Phase III Survodutide Results in Obesity
COPENHAGEN, Denmark, June 7, 2026 Zealand Pharma A/S announced that its partner Boehringer Ingelheim presented detailed results from the...
Eos SENOLYTIX Highlights PTC-2105 Preclinical Data at Obesity Forum
HOUSTON, Texas, June 5, 2026 Eos SENOLYTIX, Inc. presented new preclinical findings for its lead MitoXcel™ geropeptide candidate PTC-2105...
Cirius Therapeutics Highlights CIR-0602K as Promising New Therapy for Type 2 Diabetes
GRAND RAPIDS, Mich., June 1, 2026 Cirius Therapeutics has announced the presentation of new clinical data supporting CIR-0602K, its...
Zealand Pharma Showcases Petrelintide Obesity Data
COPENHAGEN, Denmark, May 27, 2026 Zealand Pharma announced that new clinical data from its obesity and metabolic disease pipeline...
Advertisement
